Added: Johanthan Alley - Date: 19.09.2021 00:05 - Views: 35332 - Clicks: 757
O COVID vaccine for younger age groups after reports of possible rare cardiovascular side effects. The Swedish health agency said it would pause using the shot for people born in and later as data pointed to an increase of myocarditis and pericarditis among youths and young adults that had been vaccinated.
Those conditions involve an inflammation of the heart or its lining.
Shares of Moderna fell 4. A Moderna spokesperson said in an the company was aware of the decisions by regulators in Denmark and Sweden to pause the use of its vaccine in younger individuals because of the rare risk of myocarditis and or pericarditis.
The risk of myocarditis is substantially increased for those who contract COVID, and vaccination is the best way to protect against this. According to one U. It referred to data from a yet unpublished Nordic study, which would now be sent to the European Medicines Agency EMA for further assessment.
Final data was expected within a month, it added. Ninstead. The Danish Health Authority said it had made the decision even as "heart inflammation is an extremely rare Side effects off effect that often has a mild course and goes away on its own".
The EMA's safety committee concluded in July that inflammatory heart conditions can occur in very rare cases following vaccination with Comirnaty or Spikevax, more often in younger men after the second dose. Although both vaccines are based on mRNA technology, the Pfizer shot contains 30 micrograms of vaccine per dose compared with micrograms in the Moderna vaccine.
Data from one of two U. The vaccine is not approved for people under age 18 in the United States. Norway already recommends the Cominarty vaccine to minors and said on Wednesday that it was reiterating this. A Finnish health official said Finland expected to publish a decision on Thursday.
Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox. Pharmaceutical company Merck announced on Wednesday a supply and purchase agreement with Singapore that will ensure it access to its experimental oral COVID antiviral drug, the latest Asian country aiming to get supplies.
More from Reuters. up.Side effects off
email: [email protected] - phone:(782) 913-8312 x 5302
Global COVID vaccine summary: Side effects